Keyphrases
T Cell Receptor
69%
Allogeneic Blood or Marrow Transplantation
51%
Post-transplantation Cyclophosphamide (PTCy)
51%
Confidence Interval
38%
BCL10
33%
Effector T Cells
28%
Chimeric Antigen Receptor T Cells (CAR-T)
27%
Neoantigen
27%
NF-B
27%
T Cells
26%
T Cell Receptor Signaling
25%
Nuclear factor-B
25%
Bispecific Antibody
25%
Cancer Cells
25%
T Cell Activation
20%
Graft-versus-host Disease (GvHD)
20%
Nonmyeloablative
18%
Receptor Targets
18%
Signalosome
16%
New Human Leukocyte Antigen Allele
15%
Antibody Targeting
15%
Relapsed or Refractory
15%
MALT1
15%
Immunological Synapse
15%
Improved Outcomes
15%
Nuclear factor-κB
14%
Overall Survival
14%
Tumor
14%
Electroretinogram
12%
Acute Lymphoblastic Leukemia
12%
Checkpoint Blockade
12%
Continuous Veno-venous Hemodialysis
12%
Checkpoint Blockade Therapy
12%
Chronic Lymphocytic Leukemia
12%
Allogeneic Transplantation
12%
Specific Immunotherapy
12%
Ubiquitination
12%
Blood or Marrow Transplantation
12%
High Dose
12%
TRBC1
12%
Subsequent Therapy
12%
Peripheral T-cell Lymphoma
12%
Shock
12%
Vigabatrin
12%
Checkpoint Inhibition
12%
Ras Proteins
12%
Non-Hodgkin Lymphoma
12%
Bleeding
12%
Immune Checkpoint Inhibitors
12%
NEDD4
12%
Immunology and Microbiology
T Cell Receptor
92%
T Cell
64%
Neoantigen
52%
Cyclophosphamide
38%
Cancer Cell
38%
Overall Survival
33%
Bispecific Antibody
30%
Chimeric Antigen Receptor
26%
Progression Free Survival
25%
Allele
21%
Human Leukocyte Antigen
19%
Transplant Procedure
19%
Conditioning
19%
Mouse
18%
Immunotherapy
17%
Monospecific Antibody
15%
Immunological Synapse
15%
P53
14%
Graft-Versus-Host Disease
14%
Immunoglobulin Enhancer Binding Protein
12%
Selective Autophagy
12%
Allotransplantation
12%
Drug Megadose
12%
Immune Checkpoint Blockade
12%
Recurrence Free Survival
12%
Cell Clone
12%
Heterozygosity
12%
Complement Factor B
12%
Preclinical Study
12%
Chronic Graft Versus Host Disease
11%
Cell Surface
10%
Receptor Type Tyrosine Protein Phosphatase C
9%
Infectious Agent
7%
Autophagy
7%
Wild Type
7%
Signal Transduction
6%
Acute Graft Versus Host Disease
6%
Chimeric Antigen Receptor T-Cell Therapy
6%
Sensitization
6%
B Cell
5%
Engraftment
5%
T Cell Proliferation
5%
Morbidity
5%
Gene Mutation
5%
Cell Differentiation
5%
Biochemistry, Genetics and Molecular Biology
T Cell Receptor
100%
T Cell
74%
Complement Factor B
25%
Selective Autophagy
25%
Human Leukocyte Antigen
23%
Cancer Cell
21%
Chimeric Antigen Receptor
20%
Mouse
19%
Allele
19%
Autophagy
18%
Synapse
15%
Cell Activation
14%
P53
12%
Monospecific Antibody
12%
Visual Field
12%
Nav1.5
12%
Ubiquitination
12%
Cell Clone
12%
KRAS
12%
Loss of Heterozygosity
12%
Mitochondrial Protein
12%
BCL10
12%
Surface Property
12%
NEDD4L
12%
HLA-A
12%
Immunoglobulin Enhancer Binding Protein
12%
Vision
12%
Wild Type
10%
Signal Transduction
10%
Infectious Agent
9%
Cell Proliferation
8%
Color Vision
8%
Visual Acuity
8%
Gene Mutation
6%
Cellular Differentiation
6%
Transcription Factors
6%
Isoform
6%
Diabody
6%
Phosphotransferase
5%
Kinase
5%
HLA-B
5%
